{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:18:31Z","timestamp":1794266311511,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/D\/20221658"],"award-info":[{"award-number":["BBS\/E\/D\/20221658"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/I013113\/1"],"award-info":[{"award-number":["BB\/I013113\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/M021920\/1"],"award-info":[{"award-number":["BB\/M021920\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J01446X\/1"],"award-info":[{"award-number":["BB\/J01446X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["081287\/Z\/06\/Z"],"award-info":[{"award-number":["081287\/Z\/06\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["101527\/Z\/13\/Z"],"award-info":[{"award-number":["101527\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K000276\/1"],"award-info":[{"award-number":["MR\/K000276\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12896-018-0495-1","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T02:00:27Z","timestamp":1546048827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["A chicken bioreactor for efficient production of functional cytokines"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-4421","authenticated-orcid":false,"given":"Lissa R.","family":"Herron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Pridans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lillico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel J.","family":"Gilhooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Papadakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Digard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"key":"495_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.tips.2016.10.005","volume":"37","author":"JR Kintzing","year":"2016","unstructured":"Kintzing JR, Filsinger Interrante MV, Cochran JR. Emerging strategies for developing next-generation protein therapeutics for cancer treatment. Trends Pharmacol Sci. 2016;37:993\u20131008.","journal-title":"Trends Pharmacol Sci"},{"key":"495_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nbt1204-1513","volume":"22","author":"AK Pavlou","year":"2004","unstructured":"Pavlou AK, Reichert JM. Recombinant protein therapeutics--success rates, market trends and values to 2010. Nat Biotechnol. 2004;22:1513\u20139.","journal-title":"Nat Biotechnol"},{"key":"495_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.12688\/f1000research.9970.1","volume":"6","author":"HAD Lagass\u00e9","year":"2017","unstructured":"Lagass\u00e9 HAD, Alexaki A, Simhadri VL, Katagiri NH, Jankowski W, Sauna ZE, et al. Recent advances in (therapeutic protein) drug development. F1000Res. 2017;6:113. \n                    https:\/\/doi.org\/10.12688\/f1000research.9970.1\n                    \n                  .","journal-title":"F1000Res"},{"key":"495_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40259-018-0261-x","volume":"32","author":"VP Mauro","year":"2018","unstructured":"Mauro VP. Codon optimization in the production of recombinant biotherapeutics: potential risks and considerations. BioDrugs. 2018;32:69\u201381.","journal-title":"BioDrugs"},{"key":"495_CR5","volume-title":"Making medicines affordable: a national imperative","author":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Ensuring Patient Access to Affordable Drug Therapies","year":"2017","unstructured":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Ensuring Patient Access to Affordable Drug Therapies. Making medicines affordable: a national imperative. Washington (DC): National Academies Press (US); 2017. \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493094\/\n                    \n                  . Accessed 11 Apr 2018"},{"key":"495_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/btm2.10061","volume":"2","author":"AA Shukla","year":"2017","unstructured":"Shukla AA, Wolfe LS, Mostafa SS, Norman C. Evolving trends in mAb production processes. Bioeng Transl Med. 2017;2:58\u201369.","journal-title":"Bioeng Transl Med"},{"key":"495_CR7","doi-asserted-by":"crossref","unstructured":"Dyck M, Lacroix D, Pothier F, Sirard M-A. Making recombinant proteins in animals- different systems, different applications. Trends Biotechnol. 2003;21(9):394\u20139.","DOI":"10.1016\/S0167-7799(03)00190-2"},{"key":"495_CR8","doi-asserted-by":"crossref","unstructured":"Rudolph NS. Biopharmaceutical production in transgenic livestock. Trends Biotechnol. 1999;17(9):367\u201374.","DOI":"10.1016\/S0167-7799(99)01341-4"},{"key":"495_CR9","doi-asserted-by":"crossref","unstructured":"Kues W, Niemann H. Advances in farm animal transgenesis. Prev Vet Med. 2011;102(2):146\u201356.","DOI":"10.1016\/j.prevetmed.2011.04.009"},{"key":"495_CR10","doi-asserted-by":"crossref","unstructured":"Harvey AJ, Ivarie R. Validating the hen as a bioreactor for the production of exogenous proteins in egg white. Poult Sci. 2003;82(6):927\u201330.","DOI":"10.1093\/ps\/82.6.927"},{"key":"495_CR11","doi-asserted-by":"crossref","unstructured":"Massoud M, Attal J, Th\u00e9pot D, Pointu H, Stinnakre MG, Th\u00e9ron MC, et al. The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits. Reprod Nutr Dev. 1996;36:555\u201363.","DOI":"10.1051\/rnd:19960511"},{"key":"495_CR12","doi-asserted-by":"crossref","unstructured":"Shantha R, Briggs J, Borge S, Jones A. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology. 2000;10:477\u201386.","DOI":"10.1093\/glycob\/10.5.477"},{"key":"495_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/11530550-000000000-00000","volume":"24","author":"RJ Sola","year":"2010","unstructured":"Sola RJ, Griebenow K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs. 2010;24:9\u201321.","journal-title":"BioDrugs"},{"key":"495_CR14","doi-asserted-by":"crossref","unstructured":"Zhu L, van de Lavoir M-C, Albanese J, Beenhouwer D, Cardarelli P, Cuison S, et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol. 2005;23(9):1159\u201369.","DOI":"10.1038\/nbt1132"},{"key":"495_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.bbrc.2008.01.020","volume":"367","author":"D Kodama","year":"2008","unstructured":"Kodama D, Nishimiya D, Iwata K-I, Yamaguchi K, Yoshida K, Kawabe Y, et al. Production of human erythropoietin by chimeric chickens. Biochem Biophys Res Commun. 2008;367:834\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"495_CR16","doi-asserted-by":"crossref","unstructured":"McGrew M, Sherman A, Ellard F, Lillico S, Gilhooley H, Kingsman A, et al. Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep. 2004;5(7):728\u201333.","DOI":"10.1038\/sj.embor.7400171"},{"key":"495_CR17","doi-asserted-by":"crossref","unstructured":"Lillico SG, Sherman A, McGrew MJ, Robertson CD, Smith J, Haslam C, et al. Oviduct-specific expression of two therapeutic proteins in transgenic hens. Proc Natl Acad Sci U S A. 2007;104:1771\u20136.","DOI":"10.1073\/pnas.0610401104"},{"key":"495_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3322\/canjclin.38.5.258","volume":"38","author":"D Goldstein","year":"1988","unstructured":"Goldstein D, Laszlo J. The role of interferon in cancer therapy: a current perspective. CA Cancer J Clin. 1988;38:258\u201377.","journal-title":"CA Cancer J Clin"},{"key":"495_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","volume":"132","author":"TJ Liang","year":"2000","unstructured":"Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 2000;132:296\u2013305.","journal-title":"Ann Intern Med"},{"key":"495_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.7326\/0003-4819-119-4-199308150-00011","volume":"119","author":"DK Wong","year":"1993","unstructured":"Wong DK, Cheung AM, O\u2019Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. a meta-analysis. Ann Intern Med. 1993;119:312\u201323.","journal-title":"Ann Intern Med"},{"key":"495_CR21","doi-asserted-by":"crossref","unstructured":"Hume D, MacDonald K. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood. 2012;119(2):1810\u201320.","DOI":"10.1182\/blood-2011-09-379214"},{"key":"495_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0959-440X(95)80016-T","volume":"5","author":"HR Mott","year":"1995","unstructured":"Mott HR, Campbell ID. Four-helix bundle growth factors and their receptors: protein-protein interactions. Curr Opin Struct Biol. 1995;5:114\u201321.","journal-title":"Curr Opin Struct Biol"},{"key":"495_CR23","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3389\/fimmu.2017.01860","volume":"8","author":"C Yang","year":"2017","unstructured":"Yang C, Gao X, Gong R. Engineering of fc fragments with optimized physicochemical properties implying improvement of clinical potentials for fc-based therapeutics. Front Immunol. 2017;8:1860.","journal-title":"Front Immunol"},{"key":"495_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/emmm.201201379","volume":"4","author":"DM Czajkowsky","year":"2012","unstructured":"Czajkowsky DM, Hu J, Shao ZF, Pleass RJ. Fc-fusion proteins: new developments and future perspectives. Embo Mol Med. 2012;4:1015\u201328.","journal-title":"Embo Mol Med"},{"key":"495_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/jir.2011.0048","volume":"32","author":"S Vallee","year":"2012","unstructured":"Vallee S, Rakhe S, Reidy T, Walker S, Lu Q, Sakorafas P, et al. Pulmonary administration of interferon Beta-1a-fc fusion protein in non-human primates using an immunoglobulin transport pathway. J Interf Cytokine Res. 2012;32:178\u201384.","journal-title":"J Interf Cytokine Res"},{"key":"495_CR26","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/bit.26284","volume":"114","author":"JH Lee","year":"2017","unstructured":"Lee JH, Jeong YR, Kim Y-G, Lee GM. Understanding of decreased sialylation of fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile. Biotechnol Bioeng. 2017;114:1721\u201332.","journal-title":"Biotechnol Bioeng"},{"key":"495_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2016.03.054","volume":"227","author":"C Kaisermayer","year":"2016","unstructured":"Kaisermayer C, Reinhart D, Gili A, Chang M, Aberg P-M, Castan A, et al. Biphasic cultivation strategy to avoid Epo-fc aggregation and optimize protein expression. J Biotechnol. 2016;227:3\u20139.","journal-title":"J Biotechnol"},{"key":"495_CR28","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1021\/acs.molpharmaceut.5b00550","volume":"12","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Kwak H-H, Cho SY, Sohn YB, Park SW, Huh R, et al. Pharmacokinetics, pharmacodynamics, and efficacy of a novel long-acting human growth hormone: fc fusion protein. Mol Pharm. 2015;12:3759\u201365.","journal-title":"Mol Pharm"},{"key":"495_CR29","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1053\/j.gastro.2015.08.053","volume":"149","author":"BM Stutchfield","year":"2015","unstructured":"Stutchfield BM, Antoine DJ, Mackinnon AC, Gow DJ, Bain CC, Hawley CA, et al. CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure. Gastroenterology. 2015;149:1896\u20131909.e14.","journal-title":"Gastroenterology"},{"key":"495_CR30","doi-asserted-by":"crossref","unstructured":"Gow D, Sauter K, Pridans C, Moffat L, Sehgal A, Stutchfield B, et al. Characterisation of a novel Fc conjugate of macrophage colony-stimulating factor. Mol Ther. 2014;22(9):1580\u201392.","DOI":"10.1038\/mt.2014.112"},{"key":"495_CR31","doi-asserted-by":"publisher","first-page":"G533","DOI":"10.1152\/ajpgi.00116.2016","volume":"311","author":"KA Sauter","year":"2016","unstructured":"Sauter KA, Waddell LA, Lisowski ZM, Young R, Lefevre L, Davis GM, et al. Macrophage colony-stimulating factor (CSF1) controls monocyte production and maturation and the steady-state size of the liver in pigs. Am J Physiol Gastrointest Liver Physiol. 2016;311:G533\u201347.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"495_CR32","doi-asserted-by":"publisher","first-page":"G388","DOI":"10.1152\/ajpgi.00343.2017","volume":"314","author":"C Pridans","year":"2018","unstructured":"Pridans C, Sauter KA, Irvine KM, Davis GM, Lefevre L, Raper A, et al. Macrophage colony-stimulating factor increases hepatic macrophage content, liver growth, and lipid accumulation in neonatal rats. Am J Physiol Gastrointest Liver Physiol. 2018;314:G388\u201398.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"495_CR33","doi-asserted-by":"publisher","first-page":"9263","DOI":"10.1128\/JVI.01205-16","volume":"90","author":"ML Turnbull","year":"2016","unstructured":"Turnbull ML, Wise HM, Nicol MQ, Smith N, Dunfee RL, Beard PM, et al. Role of the B allele of influenza a virus segment 8 in setting mammalian host range and pathogenicity. J Virol. 2016;90:9263\u201384.","journal-title":"J Virol"},{"key":"495_CR34","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cyto.2012.08.008","volume":"60","author":"DJ Gow","year":"2012","unstructured":"Gow DJ, Garceau V, Kapetanovic R, Sester DP, Fici GJ, Shelly JA, et al. Cloning and expression of porcine Colony stimulating Factor-1 (CSF-1) and Colony stimulating Factor-1 receptor (CSF-1R) and analysis of the species specificity of stimulation by CSF-1 and interleukin 34. Cytokine. 2012;60:793\u2013805.","journal-title":"Cytokine"},{"key":"495_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.gt.3302698","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Bohne J, Baum C, Hermann FG, Egerer L, von Laer D, et al. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther. 2006;13:641\u20135.","journal-title":"Gene Ther"},{"key":"495_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.vetimm.2017.08.006","volume":"191","author":"D Klotz","year":"2017","unstructured":"Klotz D, Baumg\u00e4rtner W, Gerhauser I. Type I interferons in the pathogenesis and treatment of canine diseases. Vet Immunol Immunopathol. 2017;191:80\u201393.","journal-title":"Vet Immunol Immunopathol"},{"key":"495_CR37","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/jbmr.354","volume":"26","author":"KA Alexander","year":"2011","unstructured":"Alexander KA, Chang MK, Maylin ER, Kohler T, M\u00fcller R, Wu AC, et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res. 2011;26:1517\u201332.","journal-title":"J Bone Miner Res"},{"key":"495_CR38","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.4049\/jimmunol.1102649","volume":"188","author":"R Kapetanovic","year":"2012","unstructured":"Kapetanovic R, Fairbairn L, Beraldi D, Sester DP, Archibald AL, Tuggle CK, et al. Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J Immunol. 2012;188:3382\u201394.","journal-title":"J Immunol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-018-0495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12896-018-0495-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-018-0495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T19:08:27Z","timestamp":1577560107000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-018-0495-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1186\/s12896-018-0495-1","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for animal experiments was obtained from The Roslin Institute\u2019s and The University of Edinburgh\u2019s Protocols and Ethics Committees. The experiments were carried out under the authority of a UK Home Office Project License under the regulations of the Animals (Scientific Procedures) Act 1986.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D.A.H. holds a patent position on the applications of CSF1-Fc in liver disease, and of CSF1 in kidney regeneration. Part of this work was performed on a collaborative grant part-funded by Zoetis, Inc. L.R.H. is now employed by Roslin Technologies, who will be commercializing the chicken platform, as well as the current proteins for use as research reagents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"82"}}